Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026
STOUGHTON, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood conditions, today announced that it will report third quarter 2026 financial results before the market opens on Thursday November 5, 2026. Following the release of the financials, the Company will host a live conference call and webcast at 8:00 a.m. ET.
Covered in this story
Call it yourself
No calls on $COLL yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Collegium Pharmaceutical Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.